Published Date: 30-Nov-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Ocular Trauma Devices Market size is expected to reach $5.3 billion by 2028, rising at a market growth of 6.7% CAGR during the forecast period.
The Ophthalmic Clinics segment is showcasing a CAGR of 6.9% during (2022 - 2028). The requirement for eye care clinics in remote and distant locations is propelling the growth of the segment. In such locations, a number of specialty clinics have opened up that cater to the specific demand of patients. This has allowed more people to adopt treatment for various eye injuries and disorders. Additionally, the number of ophthalmologists is also increasing in outlying regions.
The Implants segment acquired maximum revenue share in the Global Ocular Trauma Devices Market by Type in 2021 thereby, achieving a market value of $2.4 billion by 2028. The increasing occurrences of ocular injuries and disorders caused by other diseases are driving the growth of the segment. Diseases and disorders caused by a sedentary lifestyle have hastened the number of diabetic retinopathy that necessitates immediate treatment and surgical implants.
The Blunt Trauma segment has shown the growth rate of 6.3 % during (2022 - 2028). Blunt eye injuries are wounds or injuries usually caused by the impact of a strong blow with any instrument. Several pressures and forces in combination result in blunt trauma. The most common cause of blunt trauma includes road accidents, sports, and physical assaults. These injuries result in hyphema, vitreous hemorrhage, commotion retinae, and subconjunctival hemorrhage. Most ocular trauma incidences are blunt trauma cases.
The North America market dominated the Global Ocular Trauma Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2.1 billion by 2028. The Europe market is exhibiting a CAGR of 6.6% during (2022 - 2028). Additionally, The Asia Pacific market would showcase witness a CAGR of 7.3% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Glaukos Corporation, Alcon, Inc., EssilorLuxottica SA (Essilor Instruments USA), Bausch + Lomb Corporation (Bausch Health Companies, Inc.), Carl Zeiss AG, Topcon Corporation, CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Hoya Corporation.
Unique Offerings from KBV Research